Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

AMD Stock Has Been Crushing It Lately. This Is What Investors Should Know.
AMD Stock Has Been Crushing It Lately. This Is What Investors Should Know.

In this video, I will cover recent updates regarding Advanced Micro Devices (NASDAQ: AMD). Watch the short video to learn more, consider subscribing, and click the special offer link below.

*Stock

Why This Weight Loss Drug Company's Stock Surged Today
Why This Weight Loss Drug Company's Stock Surged Today

Shares in biopharmaceutical company Viking Therapeutics (NASDAQ: VKTX) were up by 6.3% at 12:30 a.m. ET today. The move likely stems from the market digesting the previous day's news that Viking had

VALBIOTIS SA: Valbiotis announces the success of its €6.9 million rights issue entirely dedicated to supporting the commercial expansion of its offering of dietary supplements
VALBIOTIS SA: Valbiotis announces the success of its €6.9 million rights issue entirely dedicated to supporting the commercial expansion of its offering of dietary supplements
VALBIOTIS SA: Valbiotis announces the success of its €6.9 million rights issue entirely dedicated to supporting the commercial expansion of its offering of dietary supplements
Will Palantir Technologies Stock Reach a $1 Trillion Valuation by 2027?
Will Palantir Technologies Stock Reach a $1 Trillion Valuation by 2027?

Palantir Technologies (NASDAQ: PLTR) soared 85% this year as of June 23. The data analytics company expects to grow its top line by more than 36% in 2025 as its robust artificial intelligence (AI)

Why Nektar Therapeutics Stock Was Red-Hot Today
Why Nektar Therapeutics Stock Was Red-Hot Today

The latest biotech stock to explode in price, Nektar Therapeutics (NASDAQ: NKTR) was quite the outperformer on the stock exchange for the second day in a row. On Wednesday, one day after delivering

Will AMD Stock Surprise Everyone in 2025?
Will AMD Stock Surprise Everyone in 2025?

In today's video, I discuss recent updates impacting Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the special offer link below.

3 High-Yielding Dividend Stocks to Buy for the Long Haul
3 High-Yielding Dividend Stocks to Buy for the Long Haul

The average stock on the S&P 500 yields just 1.3%. That's a modest return on your money, but that's only the average. There are many dividend stocks that pay you much more than that. While you don't

What AMD and Super Micro Computer Stock Investors Should Know About Recent Updates
What AMD and Super Micro Computer Stock Investors Should Know About Recent Updates

In today's video, I discuss recent updates impacting Advanced Micro Devices (NASDAQ: AMD), Super Micro Computer (NASDAQ: SMCI), and other semiconductor stocks. To learn more, check out the short

EQS-News: Evotec joins NURTuRE-AKI consortium to gain multi-omics-based molecular understanding of acute kidney injury
EQS-News: Evotec joins NURTuRE-AKI consortium to gain multi-omics-based molecular understanding of acute kidney injury
EQS-News: Evotec joins NURTuRE-AKI consortium to gain multi-omics-based molecular understanding of acute kidney injury
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

Cathie Wood kicked off the new trading week with one of her busiest shopping days of 2025. The CEO, co-founder, and ace stock picker at Ark Invest added to 15 of her existing stakes -- including

EQS-News: Biotests’ positive fibrinogen phase III trial results published in The Lancet’s eClinicalMedicine
EQS-News: Biotests’ positive fibrinogen phase III trial results published in The Lancet’s eClinicalMedicine
EQS-News: Biotests’ positive fibrinogen phase III trial results published in The Lancet’s eClinicalMedicine
3 Best Tech Stocks for the Second Half of 2025
3 Best Tech Stocks for the Second Half of 2025

We're nearly halfway through 2025, and what a ride it's been for the stock market. As of this writing, the S&P 500, Nasdaq Composite, and Dow Jones Industrial Index are up 2%, up 1%, and down 1%,

2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in June
2 High-Yield Healthcare Dividend Stocks to Buy Hand Over Fist in June

The healthcare sector isn't exactly known for offering huge yields, with Health Care Select Sector SPDR (NYSEMKT: XLV) offering a yield of just 1.7%. If dividend investors take some time to dig into

2 Stocks Down 34% and 40% to Buy Right Now
2 Stocks Down 34% and 40% to Buy Right Now

The first half of 2025 will draw to a close at the end of this month, and investors have been treated to some big twists and turns in the year so far. Despite some major sell-offs in the spring, the

Nvidia vs AMD: Who Will be the King of AI Chips?
Nvidia vs AMD: Who Will be the King of AI Chips?

Nvidia's (NASDAQ: NVDA) iron grip on AI chips faces a real challenger with Advanced Micro Devices' (NASDAQ: AMD). In this video, I compare the titans, break down the tech, and reveal who might rule

Here's How Many Shares of UnitedHealth Stock You Should Own to Get $1,000 in Yearly Dividends
Here's How Many Shares of UnitedHealth Stock You Should Own to Get $1,000 in Yearly Dividends

If you're seeking dividend income, bravo -- because dividends are hard to beat. Healthy and growing dividend-paying stocks will keep sending you cash, no matter whether the economy is booming or

Humana Launches “Invite” Campaign to Inspire Active Aging Through Pickleball and Community Connection
Humana Launches “Invite” Campaign to Inspire Active Aging Through Pickleball and Community Connection


Humana Inc. (NYSE: HUM), a leading health and well-being company, is expanding its commitment to senior wellness with the launch of Invite, a new campaign designed to encourage older adults of all

Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025
Dexcom Unveils New Report on Type 2 Diabetes Management in the U.S. at ADA 2025


DexCom, Inc., the global leader in glucose biosensing, today released its "Dexcom State of Type 2 Report: Access and Attitudes Across the United States" ahead of the 85th Scientific Sessions of the

2 Top Stocks to Buy With Less Than $30
2 Top Stocks to Buy With Less Than $30

Though wealthy and successful investors garner much attention on Wall Street, equity markets are accessible to the average person. That's one of the great things about investing in stocks. Even with

Why AMD Stock Rallied On Monday, and Is This Just the Beginning?
Why AMD Stock Rallied On Monday, and Is This Just the Beginning?

In today's video, I discuss recent updates impacting Advanced Micro Devices (NASDAQ: AMD) and other artificial intelligence (AI) stocks. To learn more, check out the short video, consider

2 Dividend Stocks to Buy and Never Sell
2 Dividend Stocks to Buy and Never Sell

There are excellent reasons to invest in dividend stocks, including the fact that they typically outperform their non-dividend-paying peers in delivering strong market returns over long periods.

Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth)
Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth)

When it comes to healthcare stocks, many investors pay attention to the usual suspects: Eli Lilly, Novo Nordisk, CVS Health, or Johnson & Johnson. These companies have built up enormous brand equity

UnitedHealth Group Looks to Exit Latin America. Is This a Good Move for Investors, or a Sign of More Problems Ahead?
UnitedHealth Group Looks to Exit Latin America. Is This a Good Move for Investors, or a Sign of More Problems Ahead?

UnitedHealth Group (NYSE: UNH) is in the headlines again, this time, it's to announce that it is exiting Latin America. The announcement is just the latest in a series of news events in what has

After Plummeting 40%, Where Will UnitedHealth Group Stock Be in 1 Year? Here Is What History Suggests.
After Plummeting 40%, Where Will UnitedHealth Group Stock Be in 1 Year? Here Is What History Suggests.

UnitedHealth Group (NYSE: UNH) has been one of the more interesting case studies in the stock market this year. Many stocks that have witnessed plummeting share prices can point to President Donald

EQS-Adhoc: Gerresheimer AG reacts to media reports
EQS-Adhoc: Gerresheimer AG reacts to media reports
EQS-Adhoc: Gerresheimer AG reacts to media reports